{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:39:22Z","timestamp":1792089562036,"version":"4.4.0"},"reference-count":34,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[2007,1]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Wilson\u2019s disease is a rare inborn disease related to copper storage, leading to liver cirrhosis and neuropsychological deterioration. Clinical data on larger cohorts are limited owing to low disease frequency.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective and methods:<\/jats:bold>\n                    We performed a retrospective analysis of 163 patients with Wilson\u2019s disease, examined at the University of Heidelberg, Heidelberg, Germany, to determine clinical presentation, diagnostic course and long-term outcome.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Diagnostic criteria for non-caeruloplasmin-bound serum copper, serum caeruloplasmin, 24-h urinary copper excretion, liver copper content, presence of Kayser\u2013Fleischer rings and histological signs of chronic liver damage were reached in 86.6%, 88.2%, 87.1%, 92.7%, 66.3% and 73% of patients, respectively. By analysis of the coding region of ATP7B (except exons 2, 3 and 21), disease-causing mutations were detected in 57% and 29% of patients with Wilson\u2019s disease on both chromosomes and on one chromosome, respectively. No mutations were detected in 15% of patients with Wilson\u2019s disease. No significant differences were found in clinical parameters or initial presentation between patients grouped according to their mutations. The patients with neurological symptoms were significantly older at the onset of symptoms than patients with hepatitic symptoms (20.2\n                    <jats:italic>v<\/jats:italic>\n                    15.5 years of age, p&lt;0.05), and the neurological symptoms were associated with a significantly longer time from onset to diagnosis than hepatic symptoms (44.4\n                    <jats:italic>v<\/jats:italic>\n                    14.4 months, p&lt;0.05). After initiating treatment, 76.1% of the patients had a stable or improved course of the disease. Disease progression under treatment was more likely for neuropsychiatric than for hepatic symptoms. Side effects of treatment occurred in 74.4% of patients.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Patients with Wilson\u2019s disease having predominantly neuropsychiatric symptoms manifest symptoms later, have a longer time delay from onset of symptoms until definitive diagnosis and have a poorer outcome than patients with hepatic symptoms.\n                  <\/jats:p>","DOI":"10.1136\/gut.2005.087262","type":"journal-article","created":{"date-parts":[[2006,5,18]],"date-time":"2006-05-18T20:44:04Z","timestamp":1147985044000},"page":"115-120","source":"Crossref","is-referenced-by-count":507,"title":["Clinical presentation, diagnosis and long-term outcome of Wilson\u2019s disease: a cohort study"],"prefix":"10.1136","volume":"56","author":[{"given":"U","family":"Merle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ferenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Stremmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2006,5,18]]},"reference":[{"key":"2025121305011855000_56.1.115.1","first-page":"90","volume":"7","year":"1981","journal-title":"J Rheumatol Suppl"},{"key":"2025121305011855000_56.1.115.2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1293-327"},{"key":"2025121305011855000_56.1.115.3","doi-asserted-by":"publisher","DOI":"10.1038\/ng1293-344"},{"key":"2025121305011855000_56.1.115.4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-9-720"},{"key":"2025121305011855000_56.1.115.5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.05.010"},{"key":"2025121305011855000_56.1.115.6","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50252"},{"key":"2025121305011855000_56.1.115.7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2007-1007221","volume":"16","year":"1996","journal-title":"Semin Liver Dis"},{"key":"2025121305011855000_56.1.115.8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1373.2000.22305.x"},{"key":"2025121305011855000_56.1.115.9","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2003.00824.x"},{"key":"2025121305011855000_56.1.115.10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2165\/00003495-199550020-00004","volume":"50","year":"1995","journal-title":"Drugs"},{"key":"2025121305011855000_56.1.115.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(97)90200-6"},{"key":"2025121305011855000_56.1.115.12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1212\/01.WNL.0000134793.50831.C1","volume":"63","year":"2004","journal-title":"Neurology"},{"key":"2025121305011855000_56.1.115.13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.43.1_Part_1.120","volume":"43","year":"1993","journal-title":"Neurology"},{"key":"2025121305011855000_56.1.115.14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-127-1-199707010-00004","volume":"127","year":"1997","journal-title":"Ann Intern Med"},{"key":"2025121305011855000_56.1.115.15","doi-asserted-by":"publisher","DOI":"10.1038\/ng0295-210"},{"key":"2025121305011855000_56.1.115.16","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026637403894"},{"key":"2025121305011855000_56.1.115.17","first-page":"246","volume":"7","year":"2001","journal-title":"Med Sci Monit"},{"key":"2025121305011855000_56.1.115.18","first-page":"350","volume":"113","year":"1997","journal-title":"Gastroenterology"},{"key":"2025121305011855000_56.1.115.19","first-page":"447","volume":"48","year":"1979","journal-title":"Q J Med"},{"key":"2025121305011855000_56.1.115.20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1440-1746.1992.tb01007.x","volume":"7","year":"1992","journal-title":"J Gastroenterol Hepatol"},{"key":"2025121305011855000_56.1.115.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(05)00181-3"},{"key":"2025121305011855000_56.1.115.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.07.017"},{"key":"2025121305011855000_56.1.115.23","doi-asserted-by":"publisher","DOI":"10.1086\/514864"},{"key":"2025121305011855000_56.1.115.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00219-7"},{"key":"2025121305011855000_56.1.115.25","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.10220"},{"key":"2025121305011855000_56.1.115.26","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<454::AID-HUMU7>3.0.CO;2-J"},{"key":"2025121305011855000_56.1.115.27","first-page":"398","volume":"23","year":"2004","journal-title":"Hum Mutat"},{"key":"2025121305011855000_56.1.115.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-005-0007-y"},{"key":"2025121305011855000_56.1.115.29","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.3.585"},{"key":"2025121305011855000_56.1.115.30","doi-asserted-by":"crossref","unstructured":"Merle U, Stremmel W, Gessner R. Homozygosity for methionine at codon 129 of the human prion gene delays the onset of neurological and hepatic symptoms in Wilson disease. Arch Neurol 2006;in press.","DOI":"10.1001\/archneur.63.7.982"},{"key":"2025121305011855000_56.1.115.31","first-page":"74","volume":"56","year":"1994","journal-title":"Arkh Patol"},{"key":"2025121305011855000_56.1.115.32","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.050312"},{"key":"2025121305011855000_56.1.115.33","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(87)90116-X"},{"key":"2025121305011855000_56.1.115.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(03)00157-4"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.2005.087262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T13:01:27Z","timestamp":1765630887000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.2005.087262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2006,12,15]]},"published-print":{"date-parts":[[2007,1]]}},"alternative-id":["10.1136\/gut.2005.087262"],"URL":"https:\/\/doi.org\/10.1136\/gut.2005.087262","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,18]]}}}